Insider · CIK 0001217420

YOUNG WILLIAM D

Reports to the SEC for 9 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001217420

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	AUTLAutolus Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+31.7K sh	—	—	31,667
2026-06-29	AUTLAutolus Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2026-06-10	PRAXPraxis Precision Medicines, Inc.A Award	Director	AAward	+1,371 sh	—	—	3,269
2026-06-10	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+648 sh	—	—	648
2025-06-26	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,520
2024-06-05	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,566 sh	—	—	8,566
2023-06-12	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29K sh	—	—	28,981
2022-05-26	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,753
2022-04-26	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,852 sh	—	—	78,010
2022-04-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2021-06-08	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.3K sh	—	—	22,343
2021-05-13	PRAXPraxis Precision Medicines, Inc.J Other	Director	JOther	+28.5K sh	—	—	28,473
2021-04-27	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,828 sh	—	—	68,158
2021-04-27	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+4,527 sh	—	—	4,527
2020-04-28	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,635 sh	—	—	58,330
2020-04-28	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$72.14	+$1.44M	29,311
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−2,500 sh	$217.72	−$544K	26,811
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−7,266 sh	$218.73	−$1.59M	19,545
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−10.1K sh	$219.37	−$2.22M	9,411
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−100 sh	$220.08	−$22K	9,311
2020-01-02	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$65.65	+$1.97M	39,311
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−7,402 sh	$218.05	−$1.61M	31,909
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−21.8K sh	$218.93	−$4.77M	10,111
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−500 sh	$220.25	−$110K	9,611
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−300 sh	$221.16	−$66.3K	9,311
2019-12-30	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2019-06-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+2,381 sh	—	—	9,311
2019-04-30	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+8,385 sh	—	—	51,695
2019-04-30	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2018-06-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+1,801 sh	—	—	6,930
2018-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+3,229 sh	—	—	3,229
2018-05-01	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+8,186 sh	—	—	43,310
2018-05-01	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-06-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+2,188 sh	—	—	5,129
2017-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,295 sh	—	—	5,295
2017-05-17	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,000 sh	—	—	35,124
2016-06-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+2,941 sh	$0.01	+$29.41	2,941
2016-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+7,073 sh	—	—	7,073
2016-05-03	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,000 sh	—	—	29,124
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+1,100 sh	—	—	11,875
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+3,300 sh	—	—	3,300
2015-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2015-04-22	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,000 sh	—	—	23,124
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	8,675
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2013-04-24	INVAInnoviva, Inc.A Award	Director	AAward	+6,000 sh	—	—	52,129
2013-04-24	INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000

Recent filings

Accepted (ET)
Jul 14
YOUNG WILLIAM D0001730463-26-000107
SEC(opens sec.gov)
Jun 124
YOUNG WILLIAM D0001689548-26-000062
SEC(opens sec.gov)
Jun 274
YOUNG WILLIAM D0001689548-25-000080
SEC(opens sec.gov)
Jun 64
YOUNG WILLIAM D0001689548-24-000075
SEC(opens sec.gov)
Jun 144
YOUNG WILLIAM D0001689548-23-000109
SEC(opens sec.gov)
May 274
YOUNG WILLIAM D0001689548-22-000064
SEC(opens sec.gov)
Apr 284
YOUNG WILLIAM D0001415889-22-004339
SEC(opens sec.gov)
Jul 74
YOUNG WILLIAM D0001689548-21-000069
SEC(opens sec.gov)
Jun 94
YOUNG WILLIAM D0001689548-21-000060
SEC(opens sec.gov)
Apr 294
YOUNG WILLIAM D0001179110-21-004705
SEC(opens sec.gov)
Jun 34
YOUNG WILLIAM D0001209191-20-034055
SEC(opens sec.gov)
Apr 304
YOUNG WILLIAM D0001179110-20-005307
SEC(opens sec.gov)
Jan 64
YOUNG WILLIAM D0001209191-20-001775
SEC(opens sec.gov)

Companies

Address

THE MEDIAWORKS, WHITE CITY C/O AUTOLUS THERAPEUTICS PLC

LONDON, W12 7FP